MetLife Investment Management, LLC - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 207 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$677,126
+188.0%
37,639
+14.1%
0.01%
+166.7%
Q1 2020$235,112
-70.1%
32,9750.0%0.00%
-62.5%
Q4 2019$787,443
-11.0%
32,9750.0%0.01%
-20.0%
Q3 2019$884,390
+8.9%
32,975
+10.2%
0.01%
+11.1%
Q2 2019$812,055
-21.8%
29,9320.0%0.01%
-25.0%
Q1 2019$1,038,640
+77.8%
29,9320.0%0.01%
+71.4%
Q4 2018$584,273
-26.7%
29,9320.0%0.01%
-12.5%
Q3 2018$797,089
-29.5%
29,9320.0%0.01%
-38.5%
Q2 2018$1,131,000
+35.1%
29,932
+16.9%
0.01%
+30.0%
Q1 2018$837,000
-32.9%
25,6140.0%0.01%
-28.6%
Q4 2017$1,247,00025,6140.01%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,220,672$55,602,0009.30%
Fernwood Investment Management, LLC 201,211$9,165,0007.20%
Cormorant Asset Management, LP 500,000$22,775,0003.03%
Ghost Tree Capital, LLC 170,000$7,744,0002.51%
HARVEY CAPITAL MANAGEMENT INC 155,030$7,108,0002.40%
SECTORAL ASSET MANAGEMENT INC 1,169,130$53,254,0002.22%
Atika Capital Management LLC 98,000$4,464,0002.01%
Temasek Holdings (Private) Ltd 5,833,568$265,719,0001.66%
CABOT WEALTH MANAGEMENT INC 124,309$5,662,0001.38%
EMERALD MUTUAL FUND ADVISERS TRUST 314,689$14,334,0001.11%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders